Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

21%

3 trials in Phase 3/4

Results Transparency

56%

5 of 9 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (1)
P 1 (3)
P 2 (3)
P 3 (2)
P 4 (1)

Trial Status

Completed9
Unknown3
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT05153057Recruiting

Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD)

NCT01280669Phase 2Withdrawn

Intravitreal Sirolimus as Therapeutic Approach to Uveitis

NCT01789320Phase 1Completed

Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

NCT00615693Phase 2Completed

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

NCT02746991Phase 3CompletedPrimary

Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

NCT03971279CompletedPrimary

Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis

NCT04126850Unknown

Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease

NCT00908466Phase 1Completed

Sirolimus as Therapeutic Approach to Uveitis

NCT02764697Phase 4Completed

Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients

NCT00167583Phase 3Completed

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

NCT01717170Phase 1Unknown

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

NCT00570830Not ApplicableCompleted

Retisert and Cataract Surgery in Patients With Severe Uveitis

NCT00333814Phase 2Completed

A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

NCT00407316Unknown

Quality of Life and Visual Function in Uveitis Patients

Showing all 14 trials

Research Network

Activity Timeline